Aprea Therapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Innoviva Acquisition Of Entasis Leaves

Biopharmaceutical innovation continues to try and meet patient needs regardless of whether stock prices are up or down, which is a good thing since most drug developers that went public in the US duri

There are a lot of notable financial disclosures in BioNTech AG 's US Securities and Exchange Commission (SEC) filing indicating that the company may raise up to $100m in a future initial public offe

Otsuka Pharmaceutical Co. Ltd. subsidiary Astex Pharmaceuticals Inc. plans to file for the US approval of ASTX727, an oral fixed-dose combination of decitabine and cedazuridine, by the end of this